Tag: milk allergy

November 8, 2016

DBV Technologies Completes Enrollment of Phase II Study of Viaskin Milk for the Treatment of Milk Allergic Patients

DBV Technologies, today announced that enrollment for Part B, or Phase II, of the Phase I/II study of Viaskin Milk...
September 20, 2016

DBV Technologies Receives FDA Fast Track Designation for Viaskin Milk for the Treatment of Cow’s Milk Protein Allergy

DBV Technologies (NASDAQ:DBVT), announced that the USFDA has granted Fast Track designation for Viaskin Milk, the Company’s investigational treatment for...